过去一年中添加的文章,按日期排序

[PDF][PDF] Anca D Askanase, Enxu Zhao, 2 Julie Zhu, 2 Erin Connolly-Strong, 2

RA Furie - lupus - academia.edu
14 天前 - … Objective SLE is a chronic inflammatory autoimmune … complexes and proinflammatory
cytokines. Repository … insights into the therapeutic role of RCI in refractory SLE, as …

[HTML][HTML] NLRP3 inflammasome and its role in autoimmune diseases: A promising therapeutic target

W Ren, Y Sun, L Zhao, X Shi - Biomedicine & Pharmacotherapy, 2024 - Elsevier
20 天前 - The NOD-like receptor protein 3 (NLRP3) inflammasome is a protein complex that
regulates innate immune responses by activating caspase-1 and the inflammatory cytokines

204 ZEB2 acts as a crucial transcriptional regulator governing age-associated B cell formation and pathogenicity in systemic lupus erythematosus

D Dai, S Gu, X Han, H Ding, Y Jiang, S Chen, N Shen - 2024 - lupus.bmj.com
22 天前 - Background/Purpose Age-associated B cells (ABCs) accumulate and contribute to
the pathogenesis of systemic autoimmune diseases like lupus. Despite recent insights into …

Prednisone combined with Dihydroartemisinin attenuates systemic lupus erythematosus by regulating M1/M2 balance through the MAPK signaling pathway

Y Chen, T Tao, Z Liang, X Chen, Y Xu, T Zhang… - Molecular …, 2024 - Elsevier
27 天前 - … that individuals with SLE have dysregulated levels of these cytokines compared to
the healthy … in the levels of these cytokines was observed in both SLE patients and SLE mice. …

The interplay of gut-microbiome between infection and inflammation

P Baindara, SM Mandal - Frontiers in Cellular and Infection Microbiology - frontiersin.org
37 天前 - … The gut microbiome has become a viable therapeutic target for both infectious
and … inflammasome along with increased inflammatory cytokine levels. Moreover, probiotic …

New and emerging therapies for systemic lupus erythematosus

E Papachristodoulou, VC Kyttaris - Clinical Immunology, 2024 - Elsevier
49 天前 - targets in SLE and lupus nephritis, with two new medications receiving FDA approval
in the last 3 years. Herein we provide an overview of targeted therapies for SLEcytokines. …

Chronic Inflammatory Diseases Are Causally Associated With Cardiovascular Diseases: A Mendelian Randomization Study

G Xu, M Ardissino, FS Ng - Journal of the American College of Cardiology, 2024 - jacc.org
51 天前 - … arthritis, systemic lupus erythematosus (SLE) and cytokines. … Although no specific
cytokine driver was identified as the … therapeutic targets for mitigating cardiovascular risk. …

P162 Dimethyl fumarate modulates T cell metabolism and function in systemic lupus erythematosus patient samples

L Kell, K Shah, S Taylor, R De Maeyer… - …, 2024 - academic.oup.com
52 天前 - … ; and secretion of proinflammatory cytokines from T cells patients with SLE. Taken
together … of dimethyl fumarate, with a distinct mechanism of action, as a novel therapy for SLE. …

Exploring the anti-inflammatory activity of the plant-derived phytochemical sulforaphane from cruciferous vegetables

K Treasure, J Harris, G Williamson - Proceedings of the Nutrition …, 2024 - cambridge.org
53 天前 - … Macrophage Migration Inhibitory Factor (MIF) is a pleotropic pro-inflammatory cytokine
… sclerosis, rheumatoid arthritis, and systemic lupus erythematous. Given the association …

[HTML][HTML] Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine …

J Dingfelder, M Aigner, J Taubmann… - … and Cellular Therapy, 2024 - Elsevier
58 天前 - Cytokine Release To further characterize the in vitro functionality of SLE CAR T
cells, we measured secreted cytokine levels after 16 hours. Co-culture of CAR T cells with …